22230-7 |
Coxsackievirus B3 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B3 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22230-7 |
|
|
|
|
Both |
|
|
|
0 |
CV B3 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV B3; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22231-5 |
Coxsackievirus B4 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22231-5 |
|
|
|
|
Both |
|
|
|
0 |
CV B4 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV B4; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22232-3 |
Coxsackievirus B4 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B4 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22232-3 |
|
|
|
|
Both |
|
|
|
0 |
CV B4 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV B4; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22233-1 |
Coxsackievirus B5 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22233-1 |
|
|
|
|
Both |
|
|
|
0 |
CV B5 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV B5; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22234-9 |
Coxsackievirus B5 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B5 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22234-9 |
|
|
|
|
Both |
|
|
|
0 |
CV B5 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV B5; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22235-6 |
Coxsackievirus B6 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22235-6 |
|
|
|
|
Both |
|
|
|
0 |
CV B6 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV B6; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22236-4 |
Coxsackievirus B6 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B6 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22236-4 |
|
|
|
|
Both |
|
|
|
0 |
CV B6 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV B6; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22237-2 |
Cryptococcus neoformans Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Cryptococcus neoformans Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22237-2 |
|
|
|
|
Both |
|
|
|
0 |
C neoform Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C neoform; C neoformans; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22238-0 |
Taenia solium larva Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Taenia solium larva Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22238-0 |
|
|
|
|
Both |
|
|
|
0 |
T sol lar Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cysticercosis; Cysticercus; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T sol; T sol lar; T solium; Tapeworm |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22239-8 |
Cytomegalovirus Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Cytomegalovirus Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22239-8 |
|
|
|
|
Both |
|
|
|
0 |
CMV Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated System from Ser to Ser/Plas since this test can also be performed on plasma. |
0 |
2224-4 |
Enolase |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Enolase [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2224-4 |
|
|
|
|
Both |
|
|
|
0 |
Enolase Ser-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; Phosphopyruvate dehydratase; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
22240-6 |
Cytomegalovirus Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22240-6 |
|
|
|
|
Both |
|
|
|
0 |
CMV Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22241-4 |
Cytomegalovirus Ab |
Titr |
Ser/Plas |
Pt |
SemiQn |
|
|
ACTIVE |
Cytomegalovirus Ab [Titer] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22241-4 |
|
|
|
|
Both |
|
|
|
0 |
CMV Ab Titr SerPl |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
Updated System from Ser to Ser/Plas since this test can also be performed on plasma. |
0 |
22242-2 |
Cytomegalovirus Ab |
Titr |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cytomegalovirus Ab [Titer] in Serum |
|
MIN |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22242-2 |
|
|
|
|
|
|
|
|
0 |
Deprecated CMV Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Titer; Titered; Titre; Ttr |
2.7 |
1.0n |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
22243-0 |
Cytomegalovirus Ab.IgG |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22243-0 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgG CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22244-8 |
Cytomegalovirus Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22244-8 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgG SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated System from Ser since this test can be performed on plasma specimens as well. |
0 |
22245-5 |
Cytomegalovirus Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22245-5 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgG Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22246-3 |
Cytomegalovirus Ab.IgG |
Titr |
Ser/Plas |
Pt |
SemiQn |
|
|
ACTIVE |
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22246-3 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgG Titr SerPl |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
Updated System from Ser to Ser/Plas since this test can also be performed on plasma. |
0 |
22247-1 |
Cytomegalovirus Ab.IgG^2nd specimen |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22247-1 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgG sp2 SerPl-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CMV; Convalescent; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; Spec; SR |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Updated System from Ser to Ser/Plas since this test can also be performed on plasma. |
0 |
22248-9 |
Cytomegalovirus Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22248-9 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgM Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22249-7 |
Cytomegalovirus Ab.IgM |
Titr |
Ser/Plas |
Pt |
SemiQn |
|
|
ACTIVE |
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22249-7 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgM Titr SerPl |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; Dilution factor; Dilution Factor (Titer); HHV-5; Human Herpesvirus-5; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
Updated System from Ser to Ser/Plas since this test can also be performed on plasma. |
0 |
2225-1 |
Enolase.neuron specific |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2225-1 |
|
|
|
|
Both |
|
|
|
0 |
NSE SerPl-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; ENO2; enolase 2; Gamma-enolase; NSE; Phosphopyruvate dehydratase; Phosphopyruvate hydratase.gamma subunit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tumor marker |
2.73 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
22250-5 |
Dengue virus 1 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Dengue virus 1 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22250-5 |
|
|
|
|
Both |
|
|
|
0 |
DENV1 Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type I; Denv; DENV1; Flavivirus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22251-3 |
Dengue virus 2 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Dengue virus 2 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22251-3 |
|
|
|
|
Both |
|
|
|
0 |
DENV2 Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type II; Denv; DENV2; Flavivirus; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22252-1 |
Dengue virus 3 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Dengue virus 3 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22252-1 |
|
|
|
|
Both |
|
|
|
0 |
DENV3 Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type III; Denv; DENV3; Flavivirus; ID; III; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |